Research scientist Rutledge Ellis-Behnke, left, and Professor Gerald Schneider stand by monitor showing a transected liver that has been sealed with a substance that can stop bleeding within seconds of application. Credit: Donna...

Biotechnology firm Transition Therapeutics Inc.’s (TSX:TTH) regenerative treatment for diabetes has been awarded a patent in the United States - the company informed Tuesday. A short course of injections of naturally occurring peptides can...